Reading the market regime before prices move
Reading the market regime before prices move
Every number here is computed from the traded GILD options chain. The call wall is where dealer hedging accumulates above spot and caps upside, the put wall is its mirror below, and the gamma flip is the level where hedging stops damping moves and starts amplifying them.
Computed
Last completed session, from the Finviro engine close archive · today's session levels refresh every five minutes inside the platform.
Price moves between these levels whether you see them or not. The difference is knowing them before your decision, not after.
You can check SPY, QQQ, NVDA in full right now, with no subscription.
Gilead Sciences, Inc. is a company in the Healthcare sector (Drug Manufacturers - General), listed on the NASDAQ Global Select since 1992, with a market value of about $179.47B. It is led by Daniel O'Day and has about 17,000 employees.
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key…
Its beta is 0.35: the stock is usually calmer than the broad market, so its moves are narrower than the index.
On the price was $153.57, above its 50-day simple average (DMA-50 at $147.70) by 4.0%, and above its 200-day average (DMA-200 at $138.35) by 11%. Price is above both averages: the medium- and long-term trend is up.
Revenue was $29.44B in fiscal year 2025, against $27.31B in 2021, a change of +7.8% over 4 years.
Out of every $100 of revenue, about $29 is left as net income after all costs and taxes, so the net margin is 29%.
The operating margin is 34%: what is left of revenue after operating costs, before interest and taxes.
Earnings per share were $6.84 in 2025, against $4.96 in 2021.
Free cash flow was $9.46B: the cash left after spending on operations and investment, which funds dividends and buybacks.
These numbers describe the company's size and profitability and change slowly, while gamma levels describe how the stock moves within the session.
